- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Allergan, plc
Total 15509 results
-
AllerganTerminatedOsteomyelitisUnited States
-
AllerganCompletedLong-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionOcular Hypertension | GlaucomaSpain, France, Belgium, Israel, United Kingdom, Poland, Italy, Czechia, Germany, Hungary
-
AllerganCompletedGlaucoma, Open-Angle | Normal Tension GlaucomaKorea, Republic of
-
AllerganCompleted
-
AllerganCompletedMacular DegenerationUnited States
-
AllerganCompletedHepatic ImpairmentUnited States
-
AllerganCompletedCystitis, Interstitial | Painful Bladder SyndromeUnited States, Canada
-
AllerganCompleted
-
AllerganCompletedFacial Rhytides | Glabellar RhytidesUnited States, Belgium, Germany, United Kingdom
-
AllerganCompleted
-
AllerganCompletedOsteoarthritisCzechia, United States, Denmark
-
AllerganTerminatedStroke | Muscle SpasticityUnited States, Canada
-
AllerganCompleted
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleBrazil
-
AllerganCompletedAndrogenetic AlopeciaUnited States
-
AllerganCompletedUrinary Bladder, Overactive | Urinary Bladder, NeurogenicFrance
-
AllerganCompleted
-
AllerganCompletedMigraine DisordersKorea, Republic of
-
AllerganCompletedMacular DegenerationUnited States
-
AllerganCompletedMacular Edema | Retinal Vein Occlusion | Uveitis, PosteriorFrance, Spain, Germany, United Kingdom
-
AllerganCompletedLateral Canthal Lines | Crow's Feet LinesChina
-
AllerganCompletedMid-face Volume DeficiencyAustralia
-
AllerganCompletedOveractive Bladder | Pharmacokinetics | ElderlyUnited States
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedCervical Dystonia | BlepharospasmUnited Kingdom, Mexico
-
AllerganCompleted
-
AllerganCompletedOveractive BladderPortugal, South Africa, Netherlands, Canada, Singapore, Brazil, United States, Taiwan, Italy, United Kingdom, France, Spain
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleKorea, Republic of
-
AllerganCompletedOcular Hypertension | Open-Angle GlaucomaUnited States
-
AllerganCompletedDry Eye DiseaseFrance, Spain, Russian Federation, Belgium, Germany, Italy, United Kingdom, Australia
-
AllerganCompleted
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleUnited States
-
AllerganCompleted
-
AllerganTerminated
-
AllerganCompletedAcne VulgarisUnited States
-
AllerganCompletedIdiopathic Eyelash HypotrichosisRussian Federation, Sweden, United States, United Kingdom
-
AllerganCompletedGlabellar Lines | Frown Lines | Crow's Feet Lines | Upper Facial RhytidesJapan
-
AllerganCompletedMacular Edema | Retinal Vein OcclusionDenmark, Norway, Sweden
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | Primary Open-Angle GlaucomaUnited States
-
AllerganCompletedDiabetic Macular EdemaSpain, South Africa, Canada, Czech Republic, Germany, Israel, Australia, Portugal, United States, Philippines
-
AllerganCompletedHealthy VolunteersUnited States
-
AllerganCompletedCataract | Dry Eye SyndromesChina
-
AllerganCompletedAlopecia | BaldnessUnited States, Germany
-
AllerganCompletedUrinary Bladder, OveractiveFrance, United States, Netherlands
-
AllerganWithdrawn
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleKorea, Republic of
-
AllerganCompletedConjunctivitis, AllergicUnited States
-
AllerganCompletedMigraine DisordersUnited Kingdom, United States, Switzerland, Canada, Germany, Croatia
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleUnited States